Circulation of medicinal products: intersectoral relations and directions for improving legislation

The article provides a comprehensive analysis of legislation in the field of circulation of medicines, identifies intersectoral links and identifies areas for improving the legal regulation of relations in the pharmaceutical industry. The authors raised a number of problems related to the development and unification of the conceptual apparatus used, licensing of the activity under study, contractual registration of individual stages of the movement of medicines, the introduction of new technologies that contribute to the development of personalized medicine. The article proposes the construction of model contracts accompanying clinical trials of medicines reflecting the specifics of such scientific trials, identifies the need to strengthen the information component of legislation on the circulation of medicines, taking into account the expansion of the scope of digital technologies, recommends new approaches to regulating the process of innovation, taking into account foreign experience, emphasizes the role of local acts.